netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Doxorubicin found 9 matches

Open monograph to display formulary status BNF Category
  Cytotoxic Drug Doxorubicin Malignant disease and immunosuppression - Anthracyclines and other cytotoxic antibiotics - 08.01.02
  Cytotoxic Drug Brentuximab vedotin  (Adcetris®) Malignant disease and immunosuppression - Brentuximab vedotin - 08.01.05
  Cytotoxic Drug Gemcitabine Malignant disease and immunosuppression - Antimetabolites - 08.01.03
  Polatuzumab vedotin  (Polivy®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.02)
link in drug section NICE TA389: Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.03)


 

netFormulary